Skip to main content
Premium Trial:

Request an Annual Quote

David Persing, Mitchell Mroz, Cristina Kepner, Thomas Gutshall, John Bishop, Robert Easton, Dean Morton, Kurt Petersen, Hollings Renton, Katherine Webster, Michael Olex, Michael Tognotti

Premium

Cepheid of Sunnyvale, Calif., has appointed David Persing and Mitchell Mroz to its board of directors, the company announced two weeks ago.

Persing is vice president of discovery research at Corixa and medical director of the Infectious Disease Research Institute in Seattle. In 1992, Persing established and directed the molecular microbiology laboratory at Mayo Clinic Rochester. He obtained his MD and PhD from University of California, San Francisco in 1988, according to Cepheid. He completed a residency in laboratory medicine at Yale School of Medicine.

Mroz is chairman of the board of Northrop Grumman’s Federal Credit Union and retired vice president and general manager of Northrop Grumman’s automation & information systems division. Mroz joined Northrop Grumman in 1978. He received a BS in industrial management from Purdue University in 1975 and served in the US Marine Corps Air Wing from 1962 to 1970.

Persing and Mroz join existing board members Cristina Kepner, Thomas Gutshall, John Bishop, Robert Easton, Dean Morton, Kurt Petersen, and Hollings Renton.


Katherine Webster has joined Biotage Biosystems as vice president of sales and marketing for North America, the company said last week. Prior to joining the Westborough, Mass.-based company, Webster was director of sales development at Molecular Staging. Webster holds a BS in chemistry from SUNY College of Environmental Science and Forestry, according to Biotage, which changed its name from Pyrosequencing last October.


Michael Olex has become vice president of manufacturing for BioTrove, the Woburn, Mass.-based company said last week. He joins the company from US Genomics, where he was senior vice president for manufacturing and operations. Olex holds an MS in electrical engineering from Cleveland State University, an MBA from Case Western Reserve University, and a BS in electrical engineering from the University of Detroit.


CombiMatrix has appointed Michael Tognotti as director of sales for CustomArray products in North America. Tognotti comes to CombiMatrix from Illumina, where he helped develop sales and marketing strategies for the company's oligo business. He also served as western regional sales manager for Qiagen Operon, and has held positions at Fisher Scientific and Genentech.

 

Filed under

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.